N-[1-[4-amino-7-(1H-pyrazol-5-yl)pyrazolo[4,3-c]quinolin-2-yl]propan-2-yl]-2-fluoro-2-methylpropanamide
C20H22FN7O — CID 158854488
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[4-amino-7-(1H-pyrazol-5-yl)pyrazolo[4,3-c]quinolin-2-yl]propan-2-yl]-2-fluoro-2-methylpropanamide
N-[1-[4-amino-7-(1H-pyrazol-5-yl)pyrazolo[4,3-c]quinolin-2-yl]propan-2-yl]-2-fluoro-2-methylpropanamide (PubChem CID 158854488) has the molecular formula C20H22FN7O and a molecular weight of 395.44 g/mol. Its IUPAC name is N-[1-[4-amino-7-(1H-pyrazol-5-yl)pyrazolo[4,3-c]quinolin-2-yl]propan-2-yl]-2-fluoro-2-methylpropanamide.
Molecular Properties
| Compound Name | N-[1-[4-amino-7-(1H-pyrazol-5-yl)pyrazolo[4,3-c]quinolin-2-yl]propan-2-yl]-2-fluoro-2-methylpropanamide |
|---|---|
| PubChem CID | 158854488 |
| Molecular Formula | C20H22FN7O |
| Molecular Weight | 395.44 g/mol |
| Exact Mass | 395.19 |
| IUPAC Name | N-[1-[4-amino-7-(1H-pyrazol-5-yl)pyrazolo[4,3-c]quinolin-2-yl]propan-2-yl]-2-fluoro-2-methylpropanamide |
| SMILES | CC(Cn1cc2c(N)nc3cc(-c4ccn[nH]4)ccc3c2n1)NC(=O)C(C)(C)F |
| InChI | InChI=1S/C20H22FN7O/c1-11(24-19(29)20(2,3)21)9-28-10-14-17(27-28)13-5-4-12(15-6-7-23-26-15)8-16(13)25-18(14)22/h4-8,10-11H,9H2,1-3H3,(H2,22,25)(H,23,26)(H,24,29) |
| InChIKey | IZWGVRGDNSOFCO-UHFFFAOYSA-N |
| XLogP | 2.81 |
| TPSA | 114.51 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 395.44 |
| LogP ≤ 5 | 2.81 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158854488 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.